Atsushi Kaneko < Atsushi Kawakami < Atsushi Kawashima

Facettes : Author.f AffPays.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]

Ident.	Authors (with country if any)	Title
000122 (2020)	Jumpei Temmoku [Japon] ; Yuya Fujita [Japon] ; Naoki Matsuoka [Japon] ; Takeshi Urano [Japon] ; Makiko Yashiro Furuya [Japon] ; Tomoyuki Asano [Japon] ; Shuzo Sato [Japon] ; Haruki Matsumoto [Japon] ; Hiroshi Watanabe [Japon] ; Hideko Kozuru [Japon] ; Hiroshi Yatsuhashi [Japon] ; Atsushi Kawakami [Japon] ; Kiyoshi Migita [Japon]	Uric acid-mediated inflammasome activation in IL-6 primed innate immune cells is regulated by baricitinib.
000172 (2020)	Yoshikazu Nakaoka ; Mitsuaki Isobe ; Yoshiya Tanaka ; Tomonori Ishii ; Seido Ooka ; Hiroaki Niiro [Japon] ; Naoto Tamura ; Shogo Banno ; Hajime Yoshifuji [Japon] ; Yasushi Sakata ; Atsushi Kawakami ; Tatsuya Atsumi ; Shunsuke Furuta ; Hitoshi Kohsaka ; Katsuya Suzuki ; Ryoki Hara ; Yasuhiro Maejima ; Hiroshi Tsukamoto ; Yoshinari Takasaki ; Katsuhisa Yamashita ; Norihiro Okada ; Shinji Yamakido ; Syuji Takei ; Shumpei Yokota [Japon] ; Norihiro Nishimoto [Japon]	Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
000189 (2020)	Tomohiro Koga ; Naoko Hagimori [Japon] ; Shuntaro Sato [Japon] ; Shinpei Morimoto [Japon] ; Naoki Hosogaya [Japon] ; Chizu Fukushima [Japon] ; Hiroshi Yamamoto [Japon] ; Atsushi Kawakami	An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance: Study protocol for investigator-initiated, multicenter, open-label trial.
000228 (2019)	Tomohisa Uchida ; Momoko Okamoto ; Keita Fujikawa ; Daisuke Yoshikawa ; Akinari Mizokami ; Tomo Mihara ; Akira Kondo ; Kazuo Ohba ; Kazuhiro Kurohama ; Masahiro Nakashima ; Ichiro Sekine ; Shigeki Nakamura [Japon] ; Yoshitsugu Miyazaki [Japon] ; Atsushi Kawakami [Japon]	Gastric mucormycosis complicated by a gastropleural fistula: A case report and review of the literature.
000339 (2019)	Ryuki Sakaguchi [Japon] ; Keita Fujikawa [Japon] ; Momoko Okamoto [Japon] ; Emi Matsuo [Japon] ; Kohei Matsumoto [Japon] ; Tomohisa Uchida [Japon] ; Kawashiri Shin-Ya [Japon] ; Masahiro Nakashima [Japon] ; Akinari Mizokami [Japon] ; Atsushi Kawakami [Japon]	Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder.
000507 (2019)	Erika Aikawa [Japon] ; Toshimasa Shimizu [Japon] ; Tomohiro Koga [Japon] ; Yushiro Endo [Japon] ; Masataka Umeda [Japon] ; Tomoko Hori [Japon] ; Junji Irie [Japon] ; Kishio Kuroda [Japon] ; Mizuna Eguchi [Japon] ; Momoko Okamoto [Japon] ; Sosuke Tsuji [Japon] ; Ayuko Takatani [Japon] ; Takashi Igawa [Japon] ; Remi Sumiyoshi [Japon] ; Shin-Ya Kawashiri [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Atsushi Kawakami [Japon]	Atypical Familial Mediterranean Fever Complicated with Gastrointestinal Amyloidosis Diagnosed due to Paroxysmal Arthralgia and Intractable Diarrhea, Successfully Treated with Tocilizumab.
000534 (2018)	Masataka Umeda [Japon] ; Tomohiro Koga [Japon] ; Kunihiro Ichinose [Japon] ; Ayuko Takatani [Japon] ; Takashi Igawa [Japon] ; Toshimasa Shimizu [Japon] ; Shoichi Fukui [Japon] ; Ayako Nishino [Japon] ; Yoshiro Horai [Japon] ; Yasuko Hirai [Japon] ; Shin-Ya Kawashiri [Japon] ; Naoki Iwamoto [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Toshiyuki Aramaki [Japon] ; Yukitaka Ueki [Japon] ; Akitomo Okada [Japon] ; Keita Fujikawa [Japon] ; Naoki Matsuoka [Japon] ; Atsushi Kawakami [Japon]	Efficacy of infliximab as a switched biologic in rheumatoid arthritis patients in daily clinical practice.
000549 (2018)	Tomohiro Koga [Japon] ; Shuntaro Sato [Japon] ; Junya Miyamoto [Japon] ; Naoko Hagimori [Japon] ; Yurika Kawazoe [Japon] ; Kumiko Arinaga [Japon] ; Chizu Fukushima [Japon] ; Hiroshi Yamamoto [Japon] ; Atsushi Kawakami [Japon]	Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
000642 (2019)	Tomohiro Koga [Japon] ; Remi Sumiyoshi [Japon] ; Atsushi Kawakami [Japon] ; Kazuyuki Yoshizaki [Japon]	A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease.
000A53 (2017)	Jin Nakagawa [Japon] ; Yoshinobu Koyama [Japon] ; Atsushi Kawakami [Japon] ; Yukitaka Ueki [Japon] ; Hiroshi Tsukamoto [Japon] ; Takahiko Horiuchi [Japon] ; Shuji Nagano [Japon] ; Ayumi Uchino [Japon] ; Toshiyuki Ota [Japon] ; Mitsuteru Akahoshi [Japon] ; Koichi Akashi [Japon]	A novel scoring system based on common laboratory tests predicts the efficacy of TNF-inhibitor and IL-6 targeted therapy in patients with rheumatoid arthritis: a retrospective, multicenter observational study.
000B54 (2017)	Naoki Iwamoto [Japon] ; Sosuke Tsuji [Japon] ; Ayuko Takatani [Japon] ; Toshimasa Shimizu [Japon] ; Shoichi Fukui [Japon] ; Masataka Umeda [Japon] ; Ayako Nishino [Japon] ; Yoshiro Horai [Japon] ; Tomohiro Koga [Japon] ; Shin-Ya Kawashiri [Japon] ; Toshiyuki Aramaki [Japon] ; Kunihiro Ichinose [Japon] ; Yasuko Hirai [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Kaoru Terada [Japon] ; Tomoki Origuchi [Japon] ; Katsumi Eguchi [Japon] ; Yukitaka Ueki [Japon] ; Atsushi Kawakami [Japon]	Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis.
000E05 (????)	Shin-Ya Kawashiri [Japon] ; Ayako Nishino [Japon] ; Takahisa Suzuki [Japon] ; Yoshikazu Nakashima [Japon] ; Yoshiro Horai [Japon] ; Yukitaka Ueki [Japon] ; Toshiyuki Aramaki [Japon] ; Keita Fujikawa [Japon] ; Munetoshi Nakashima [Japon] ; Akitomo Okada [Japon] ; Kiyoshi Migita [Japon] ; Akinari Mizokami [Japon] ; Naoki Matsuoka [Japon] ; Masanobu Mine [Japon] ; Soko Sakito [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Kiyoshi Aoyagi [Japon] ; Katsumi Eguchi [Japon] ; Atsushi Kawakami [Japon]	Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practice.
000E81 (2016)	Shinichiro Tsurukawa [Japon] ; Nozomi Iwanaga [Japon] ; Yasumori Izumi [Japon] ; Atsunori Shirakawa [Japon] ; Chieko Kawahara [Japon] ; Tetsuo Shukuwa [Japon] ; Miwako Inamoto [Japon] ; Atsushi Kawakami [Japon] ; Kiyoshi Migita [Japon]	Herpes Zoster Meningitis Complicating Combined Tocilizumab and Cyclosporine Therapy for Adult-Onset Still's Disease.
000F27 (2016)	Tomohiro Koga ; Kiyoshi Migita ; Atsushi Kawakami	Biologic therapy in familial Mediterranean fever.
000F90 (2016)	Naoki Iwamoto [Japon] ; Shoichi Fukui [Japon] ; Masataka Umeda [Japon] ; Ayako Nishino [Japon] ; Yoshikazu Nakashima [Japon] ; Takahisa Suzuki [Japon] ; Yoshiro Horai [Japon] ; Fumiaki Nonaka [Japon] ; Akitomo Okada [Japon] ; Tomohiro Koga [Japon] ; Shin-Ya Kawashiri [Japon] ; Keita Fujikawa [Japon] ; Toshiyuki Aramaki ; Kunihiro Ichinose [Japon] ; Yasuko Hirai [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Kaoru Terada ; Munetoshi Nakashima [Japon] ; Akinari Mizokami [Japon] ; Tomoki Origuchi [Japon] ; Katsumi Eguchi [Japon] ; Yukitaka Ueki ; Atsushi Kawakami [Japon]	Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis.
001034 (2017)	Masataka Umeda [Japon] ; Toshiyuki Aramaki [Japon] ; Keita Fujikawa [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Kaoru Terada [Japon] ; Gou Takeo [Japon] ; Nobuhisa Yonemitsu [Japon] ; Yukitaka Ueki [Japon] ; Kiyoshi Migita [Japon] ; Atsushi Kawakami [Japon]	Tocilizumab is effective in a familial Mediterranean fever patient complicated with histologically proven recurrent fasciitis and myositis.
001184 (2015)	Atsushi Ogata ; Koichi Amano ; Hiroaki Dobashi ; Masayuki Inoo ; Tomonori Ishii ; Tsuyoshi Kasama ; Shinichi Kawai ; Atsushi Kawakami ; Tatsuya Koike ; Hisaaki Miyahara ; Toshiaki Miyamoto ; Yasuhiko Munakata ; Akira Murasawa ; Norihiro Nishimoto ; Noriyoshi Ogawa ; Tomohiro Ojima ; Hajime Sano ; Kenrin Shi ; Eisuke Shono ; Eiichi Suematsu ; Hiroki Takahashi ; Yoshiya Tanaka ; Hiroshi Tsukamoto ; Akira Nomura	Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study.
001545 (2015)	Shin-Ya Kawashiri [Japon] ; Takahisa Suzuki [Japon] ; Yoshikazu Nakashima [Japon] ; Yoshiro Horai [Japon] ; Akitomo Okada [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Mami Tamai [Japon] ; Kazuhiko Arima [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Masataka Uetani [Japon] ; Kiyoshi Aoyagi [Japon] ; Atsushi Kawakami [Japon]	Confirmation of effectiveness of tocilizumab by ultrasonography and magnetic resonance imaging in biologic agent-naïve early-stage rheumatoid arthritis patients.
001565 (????)	Keita Fujikawa [Japon] ; Kiyoshi Migita ; Toshiaki Tsukada ; Masataka Umeda ; Fumiaki Nonaka ; Atsushi Kawakami ; Katsumi Eguchi	Interleukin-6 targeting therapy in familial Mediterranean fever.
001605 (2013)	Hideki Nakamura [Japon] ; Yukitaka Ueki ; Shigeki Saito ; Yoshiro Horai ; Takahisa Suzuki ; Tomoki Naoe ; Katsumi Eguchi ; Atsushi Kawakami	Development of adult T-cell leukemia in a patient with rheumatoid arthritis treated with tocilizumab.
001874 (2012)	Ryoko Sakai [Japon] ; Michi Tanaka ; Toshihiro Nanki ; Kaori Watanabe ; Hayato Yamazaki ; Ryuji Koike ; Hayato Nagasawa ; Koichi Amano ; Kazuyoshi Saito ; Yoshiya Tanaka ; Satoshi Ito ; Takayuki Sumida ; Atsushi Ihata ; Yoshiaki Ishigatsubo ; Tatsuya Atsumi ; Takao Koike ; Atsuo Nakajima ; Naoto Tamura ; Takao Fujii ; Hiroaki Dobashi ; Shigeto Tohma ; Takahiko Sugihara ; Yukitaka Ueki ; Akira Hashiramoto ; Atsushi Kawakami ; Noboru Hagino ; Nobuyuki Miyasaka ; Masayoshi Harigai	Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "Atsushi Kawakami" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i  \
                -Sk "Atsushi Kawakami" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    Atsushi Kawakami
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021